1. Home
  2. XPON vs CANF Comparison

XPON vs CANF Comparison

Compare XPON & CANF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Expion360 Inc.

XPON

Expion360 Inc.

HOLD

Current Price

$0.53

Market Cap

7.3M

Sector

Technology

ML Signal

HOLD

Logo Can-Fite Biopharma Ltd Sponsored ADR (Israel)

CANF

Can-Fite Biopharma Ltd Sponsored ADR (Israel)

HOLD

Current Price

$3.39

Market Cap

7.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XPON
CANF
Founded
2016
1994
Country
United States
Israel
Employees
N/A
N/A
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
7.2M
IPO Year
2022
2011

Fundamental Metrics

Financial Performance
Metric
XPON
CANF
Price
$0.53
$3.39
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$50.00
AVG Volume (30 Days)
136.9K
942.3K
Earning Date
05-14-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
94.63
N/A
EPS
N/A
N/A
Revenue
$9,651,870.00
N/A
Revenue This Year
N/A
$2,715,455.50
Revenue Next Year
N/A
$101.06
P/E Ratio
N/A
N/A
Revenue Growth
71.59
N/A
52 Week Low
$0.49
$0.17
52 Week High
$5.50
$10.40

Technical Indicators

Market Signals
Indicator
XPON
CANF
Relative Strength Index (RSI) 27.73 52.09
Support Level $0.49 $2.89
Resistance Level $0.84 $4.74
Average True Range (ATR) 0.05 0.30
MACD -0.02 0.00
Stochastic Oscillator 13.07 49.57

Price Performance

Historical Comparison
XPON
CANF

About XPON Expion360 Inc.

Expion360 Inc focuses on the design, assembly, manufacturing, and sale of lithium iron phosphate (LiFePO4) batteries and related accessories for RV, marine, and industrial applications. Its high-performance battery solutions are designed for high energy density and a compact footprint, supported by engineering and intellectual property to enhance safety, quality, and performance. The company also engages in product design, development, and collaboration to strengthen customer relationships. It serves dealers, wholesalers, private-label customers, and OEMs, who distribute its products to end consumers. Its segment is Energy Storage (ES), providing lithium-based energy solutions backed by durable materials, optimized internal structures, and responsive customer service.

About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Share on Social Networks: